Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aptos (APT) vs Immunefi (IMU) Price & Performance

Price performance (Past 24H)

Key statistics

Aptos vs Immunefi — how do they compare? Aptos trades at Rp9,999 (market cap Rp8,56T, Rp427,87M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Aptos is far larger — about 316685.2× Immunefi's market cap, and Aptos's circulating supply is 857,4M / 2,1B APT (41%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 33 Days and Immunefi for 5 Days on average.

APTIMU
Market Cap
Rp8,56TRp27,03M
Volume (24h)
Rp427,87MRp39,91M
Circulating Supply
857,4M / 2,1B APT (41%)873,4M / 10B IMU (9%)
Typical Hold Time
33 Days5 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aptos

Aptos is trading at Rp9,982, showing bearish technical signals with moving averages indicating sell pressure, though oscillators are neutral. The current price is near support at Rp9,820, with resistance at Rp10,260. Market cap stands at Rp8.57T with 41% of max supply in circulation. No major protocol updates or ecosystem news were noted recently.

Outlook remains cautious due to bearish trends and limited fundamental catalysts. Key risks include high volatility and regulatory uncertainty, while potential support near current levels may offer short-term stability. Investors should monitor network activity for signs of adoption.

Immunefi

Immunefi (IMU) presents a unique crypto asset with a modest market cap of Rp27.03M and only 9% circulating supply, indicating significant token lockup. The 5-day average hold time suggests short-term trading activity. Current technical analysis is limited due to missing price data, but the low circulation rate and small market cap point to high volatility potential. Recent news coverage appears to focus on corporate equity analysis rather than blockchain fundamentals, creating information asymmetry for crypto investors.

Overall outlook remains speculative with limited fundamental data. Key opportunity lies in potential token unlocks and ecosystem growth, while major risks include extreme volatility from low liquidity, regulatory uncertainty, and lack of clear crypto-specific utility. Investors should approach with caution given the asset's early stage and limited market data availability.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

APT
69% Buy31% Sell
Avg holding period · 33 Days
IMU

No sentiment data available yet.

Top news

Latest headlines on both assets

About Aptos

Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.

Read more on APT

About Immunefi

Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.

Read more on IMU